Comparison of Three Different Puncture Techniques in EBUS-TBNA

Sponsor
Beijing Friendship Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05628454
Collaborator
(none)
75
1
3
24
3.1

Study Details

Study Description

Brief Summary

The purpose of this study was to compare the accuracy and sensitivity of slow-pull capillary technique, traditional suction aspiration and non negative pressure puncture in the diagnosis of mediastinal and/or hilar lymph node enlargement by ultrasound bronchoscopic lymph node biopsy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endobronchial ultrasound-guided transbronchial needle Slow-pull capillary sampling
  • Procedure: Endobronchial ultrasound-guided transbronchial needle aspiration
  • Procedure: Endobronchial ultrasound-guided transbronchial needle capillary sampling
N/A

Detailed Description

EBUS-TBNA has been widely used in the diagnosis of diseases involving lung hilar and mediastinal lymph node enlargement.But different puncture methods are still controversial. Research shows that there was no significant difference in sample adequacy, diagnostic specificity and accuracy between the no negative pressure aspiration and traditional negative pressure aspiration technique.Slow-pull capillary technique is a relatively new operating method of endoscopic ultrasound guided fine needle biopsy in recent years. At present, this technology is widely used in pancreatic space occupying lesions. Compared with the traditional negative pressure aspiration method, our previous retrospective study found that the slow-pull capillary technique can improve the diagnostic accuracy of patients. Therefore, the purpose of this study is to prospectively and randomly compare the advantages and disadvantages of three puncture methods in EBUS-TBNA.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
75 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
The operator knows which puncture technique to be used, but the subject and the outcomes assessor does not know the technique.
Primary Purpose:
Diagnostic
Official Title:
Comparison of Three Different Puncture Techniques in EBUS-TBNA
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: EBUS-TBNSP

The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.

Procedure: Endobronchial ultrasound-guided transbronchial needle Slow-pull capillary sampling
The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.
Other Names:
  • Slow-pull capillary technique
  • Experimental: EBUS-TBNA

    The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.

    Procedure: Endobronchial ultrasound-guided transbronchial needle aspiration
    The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.
    Other Names:
  • Standard suction
  • Experimental: EBUS-TBNCS

    The operation steps are the same as above, but there is no negative pressure device behind the puncture needle

    Procedure: Endobronchial ultrasound-guided transbronchial needle capillary sampling
    The operation steps are the same as above, but there is no negative pressure device behind the puncture needle
    Other Names:
  • Fine needle sampling without suction
  • Outcome Measures

    Primary Outcome Measures

    1. Diagnostic accuracy of three different puncture methods according to pathological diagnosis [6 months]

      The final pathological diagnosis was based on all available cytological and histological samples. In cases with negative pathological results , we continue to follow up the patients for ⩾6months.

    Secondary Outcome Measures

    1. Blood contamination of samples [1 week]

      Blood contamination was categorized as follows: low (no or few blood cells influencing the diagnosis), moderate (sample partially obscured by blood cells, but pathological diagnosis possible), and high (large numbers of blood cells, rendering pathological diagnosis difficult)

    2. Bleeding of operation [1 week]

      There are three levels of bleeding:Small amount of bleeding(Ⅰ): Bleeding can stop spontaneously without continuous suction.Moderate bleeding(Ⅱ): Continuous suction is required, and epinephrine or ice salt water is used locally to stop bleeding.Massive bleeding(Ⅲ): Patients who need to be used balloon compression, interventional treatment, or blood transfusion treatment or even died of asphyxia due to bleeding.

    3. Acquisition of tissue core of three different puncture methods according to the judgment of the pathologist [1 week]

      Tissue cores were immersed in formalin solution and subjected to histopathological examination. In the absence of a tissue core, the contents were pressed onto a glass slide, immersed in 96% methanol for ⩾10min and subjected to cytopathological examination.Some methods may only obtain cytological specimens, while others may obtain tissue cores. Tissue cores are better for pathologists to diagnose.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18-80years

    • Chest computed tomography showing hilar or mediastinal lymph node enlargement

    • No contraindications for bronchoscopy

    • Signed informed consent provided by the patient

    • Disease needs to be diagnosed through the EBUS-TBNA

    Exclusion Criteria:
    • Severe coagulation dysfunction

    • Severe cardiopulmonary dysfunction

    • Acute asthma attack or massive haemoptysis

    • Poor general condition

    • Physical weakness without tolerance for anaesthesia or allergy to narcotic drug

    • Disease can be diagnosed by other less invasive methods (such as skin or peripheral superficial lymph node biopsy)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beijing Friendship Hospital, Capital Medical University Beijing Beijing China 100050

    Sponsors and Collaborators

    • Beijing Friendship Hospital

    Investigators

    • Principal Investigator: Yanjun Wu, Beijing Friendship Hospital
    • Study Director: Zhigang Yao, Beijing Friendship Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Beijing Friendship Hospital
    ClinicalTrials.gov Identifier:
    NCT05628454
    Other Study ID Numbers:
    • BFH20221019005
    First Posted:
    Nov 28, 2022
    Last Update Posted:
    Nov 28, 2022
    Last Verified:
    Nov 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 28, 2022